John H. Barton

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Sharlene Litchy, John H. Barton et al. · Journal of Clinical Oncology · 2003 · 350 citations

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma

John D. Hainsworth, Howard A. Burris, Sharlene Litchy et al. · Cancer · 2000 · 140 citations

Gemcitabine, Carboplatin, and Paclitaxel for Patients With Carcinoma of Unknown Primary Site: A Minnie Pearl Cancer Research Network Study

F. Anthony Greco, Howard A. Burris, Sharlene Litchy et al. · Journal of Clinical Oncology · 2002 · 111 citations

Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

John D. Hainsworth, Anthony A. Meluch, David R. Spigel et al. · Clinical Genitourinary Cancer · 2007 · 51 citations

Urology, Genitourinary Cancer, Medicine +8

A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer

Denise A. Yardley, Howard A. Burris, Lisa Simons et al. · Clinical Breast Cancer · 2008 · 43 citations

Metastatic Breast Cancer, Breast Oncology, Phase Ii Trial +7